Filing Flows › InfuSystem Holdings (INFU) › Guidance & outlook
InfuSystem Holdings (INFU) guidance and outlook
InfuSystem Holdings (INFU) raised its guidance on Nov 5, 2026: EBITDA margin 20% for FY2026; Revenue $7.1M for FY2025; Revenue $2.4M for FY2026.
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2026 | +6% to +8% | new |
| EBITDA margin | FY2026 | 20% | reaffirmed |
| Revenue | FY2025 | $7.1M | reaffirmed |
| Revenue | FY2026 | $2.4M | raised |
From the earnings release filed Nov 5, 2026 (8-K on EDGAR).
InfuSystem Holdings' latest quarter
InfuSystem Holdings, Q3 2026: revenue $37.6M (+3% year over year), operating margin 12.6%, net earnings $3.2M, operating cash flow $10.3M. The chart follows the revenue to costs, profit and cash.
Questions
Did InfuSystem Holdings raise or lower its guidance?
InfuSystem Holdings (INFU) raised its guidance on Nov 5, 2026: EBITDA margin 20% for FY2026; Revenue $7.1M for FY2025; Revenue $2.4M for FY2026.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.